438 related articles for article (PubMed ID: 33953176)
1. Loss of Ambra1 promotes melanoma growth and invasion.
Di Leo L; Bodemeyer V; Bosisio FM; Claps G; Carretta M; Rizza S; Faienza F; Frias A; Khan S; Bordi M; Pacheco MP; Di Martino J; Bravo-Cordero JJ; Daniel CJ; Sears RC; Donia M; Madsen DH; Guldberg P; Filomeni G; Sauter T; Robert C; De Zio D; Cecconi F
Nat Commun; 2021 May; 12(1):2550. PubMed ID: 33953176
[TBL] [Abstract][Full Text] [Related]
2. Ambra1 modulates the tumor immune microenvironment and response to PD-1 blockade in melanoma.
Frias A; Di Leo L; Antoranz A; Nazerai L; Carretta M; Bodemeyer V; Pagliuca C; Dahl C; Claps G; Mandelli GE; Andhari MD; Pacheco MP; Sauter T; Robert C; Guldberg P; Madsen DH; Cecconi F; Bosisio FM; De Zio D
J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 36868570
[TBL] [Abstract][Full Text] [Related]
3. AMBRA1 has an impact on melanoma development beyond autophagy.
Di Leo L; De Zio D
Autophagy; 2021 Jul; 17(7):1802-1803. PubMed ID: 34156327
[TBL] [Abstract][Full Text] [Related]
4. AMBRA1 and FAK1: crosstalking for improved targeted therapy in melanoma.
Di Leo L; De Zio D
Mol Cell Oncol; 2021; 8(4):1949955. PubMed ID: 34616874
[TBL] [Abstract][Full Text] [Related]
5. Atg7 Overcomes Senescence and Promotes Growth of BrafV600E-Driven Melanoma.
Xie X; Koh JY; Price S; White E; Mehnert JM
Cancer Discov; 2015 Apr; 5(4):410-23. PubMed ID: 25673642
[TBL] [Abstract][Full Text] [Related]
6. Exploiting cannabinoid-induced cytotoxic autophagy to drive melanoma cell death.
Armstrong JL; Hill DS; McKee CS; Hernandez-Tiedra S; Lorente M; Lopez-Valero I; Eleni Anagnostou M; Babatunde F; Corazzari M; Redfern CPF; Velasco G; Lovat PE
J Invest Dermatol; 2015 Jun; 135(6):1629-1637. PubMed ID: 25674907
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of autophagy-related proteins expression in resected human gastric adenocarcinoma.
Qu B; Yao L; Ma HL; Chen HL; Zhang Z; Xie J
J Huazhong Univ Sci Technolog Med Sci; 2017 Feb; 37(1):37-43. PubMed ID: 28224423
[TBL] [Abstract][Full Text] [Related]
8. Sema6A and Mical1 control cell growth and survival of BRAFV600E human melanoma cells.
Loria R; Bon G; Perotti V; Gallo E; Bersani I; Baldassari P; Porru M; Leonetti C; Di Carlo S; Visca P; Brizzi MF; Anichini A; Mortarini R; Falcioni R
Oncotarget; 2015 Feb; 6(5):2779-93. PubMed ID: 25576923
[TBL] [Abstract][Full Text] [Related]
9. Abl kinase regulation by BRAF/ERK and cooperation with Akt in melanoma.
Jain A; Tripathi R; Turpin CP; Wang C; Plattner R
Oncogene; 2017 Aug; 36(32):4585-4596. PubMed ID: 28368422
[TBL] [Abstract][Full Text] [Related]
10. AMBRA1 and BECLIN 1 interplay in the crosstalk between autophagy and cell proliferation.
Cianfanelli V; D'Orazio M; Cecconi F
Cell Cycle; 2015; 14(7):959-63. PubMed ID: 25803737
[TBL] [Abstract][Full Text] [Related]
11. Nck2 promotes human melanoma cell proliferation, migration and invasion in vitro and primary melanoma-derived tumor growth in vivo.
Labelle-Côté M; Dusseault J; Ismaïl S; Picard-Cloutier A; Siegel PM; Larose L
BMC Cancer; 2011 Oct; 11():443. PubMed ID: 21992144
[TBL] [Abstract][Full Text] [Related]
12. The autophagy protein Ambra1 regulates gene expression by supporting novel transcriptional complexes.
Schoenherr C; Byron A; Griffith B; Loftus A; Wills JC; Munro AF; von Kriegsheim A; Frame MC
J Biol Chem; 2020 Aug; 295(34):12045-12057. PubMed ID: 32616651
[TBL] [Abstract][Full Text] [Related]
13. miR-216b enhances the efficacy of vemurafenib by targeting Beclin-1, UVRAG and ATG5 in melanoma.
Luo M; Wu L; Zhang K; Wang H; Wu S; O'Connell D; Gao T; Zhong H; Yang Y
Cell Signal; 2018 Jan; 42():30-43. PubMed ID: 28982601
[TBL] [Abstract][Full Text] [Related]
14. Odontogenic ameloblast-associated protein (ODAM) inhibits growth and migration of human melanoma cells and elicits PTEN elevation and inactivation of PI3K/AKT signaling.
Foster JS; Fish LM; Phipps JE; Bruker CT; Lewis JM; Bell JL; Solomon A; Kestler DP
BMC Cancer; 2013 May; 13():227. PubMed ID: 23648148
[TBL] [Abstract][Full Text] [Related]
15. Concomitant Inhibition of PI3Kβ and BRAF or MEK in PTEN-Deficient/BRAF-Mutant Melanoma Treatment: Preclinical Assessment of SAR260301 Oral PI3Kβ-Selective Inhibitor.
Bonnevaux H; Lemaitre O; Vincent L; Levit MN; Windenberger F; Halley F; Delorme C; Lengauer C; Garcia-Echeverria C; Virone-Oddos A
Mol Cancer Ther; 2016 Jul; 15(7):1460-71. PubMed ID: 27196754
[TBL] [Abstract][Full Text] [Related]
16. Ambra1 spatially regulates Src activity and Src/FAK-mediated cancer cell invasion via trafficking networks.
Schoenherr C; Byron A; Sandilands E; Paliashvili K; Baillie GS; Garcia-Munoz A; Valacca C; Cecconi F; Serrels B; Frame MC
Elife; 2017 Mar; 6():. PubMed ID: 28362576
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylated 4E-BP1 is associated with poor survival in melanoma.
O'Reilly KE; Warycha M; Davies MA; Rodrik V; Zhou XK; Yee H; Polsky D; Pavlick AC; Rosen N; Bhardwaj N; Mills G; Osman I
Clin Cancer Res; 2009 Apr; 15(8):2872-8. PubMed ID: 19336517
[TBL] [Abstract][Full Text] [Related]
18. BRN2 is a non-canonical melanoma tumor-suppressor.
Hamm M; Sohier P; Petit V; Raymond JH; Delmas V; Le Coz M; Gesbert F; Kenny C; Aktary Z; Pouteaux M; Rambow F; Sarasin A; Charoenchon N; Bellacosa A; Sanchez-Del-Campo L; Mosteo L; Lauss M; Meijer D; Steingrimsson E; Jönsson GB; Cornell RA; Davidson I; Goding CR; Larue L
Nat Commun; 2021 Jun; 12(1):3707. PubMed ID: 34140478
[TBL] [Abstract][Full Text] [Related]
19. MIR7-3HG, a MYC-dependent modulator of cell proliferation, inhibits autophagy by a regulatory loop involving AMBRA1.
Capizzi M; Strappazzon F; Cianfanelli V; Papaleo E; Cecconi F
Autophagy; 2017 Mar; 13(3):554-566. PubMed ID: 28059583
[TBL] [Abstract][Full Text] [Related]
20. Ambra1 in cancer: implications for clinical oncology.
Qin YQ; Liu SY; Lv ML; Sun WL
Apoptosis; 2022 Oct; 27(9-10):720-729. PubMed ID: 35994214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
